Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC

Clinical trial NCT07509099 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07509099
Sponsor: Ji Dongmei
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck

Start date: 2026-04-01
Primary completion: 2030-09-30
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.